Answers are grounded in this paper and cite their sources.
Background: High-risk cases for NAFLD are currently underreported or not identified in a timely manner.It is important to elucidate the clinical behavior of the interaction of clinical values in metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD), considering the complications that may occur in the group of patients with this comorbidity.Methods: A total of 1,604 adults diagnosed with metabolic syndrome (MetS) and nonalcoholic fatty liver disease (NAFLD) were randomly selected for a cross-sectional study.Metabolic status and non-alcoholic fatty liver disease were measured using the MetS Metabolic Syndrome Diagnostic Criteria (NCEP/ATP-III), laboratory tests, and diagnostic imaging, respectively.Results: In the study no significant differences were found between the two groups in age (p=0.379) and sex (p=0.146),although a higher prevalence was found in women after menopause.BMI (Body mass index) was significantly higher in the NAFLD group than in the comparison group (p=0.827).According to the NCEP/ATPIII criteria (0.941), there was a significant association between MetS and NAFLD.Mean MetS components were higher in the NAFLD group than in the comparison group.MetS values and the presence of NAFLD are compared at each clinical value.It is shown that the evaluated clinical values of MetS presented a significant association with NAFLD (p=0.841).The clinical values corresponding to blood pressure (p=0.721/p=0.675), triglycerides (p=0.740),fasting blood glucose (p=0.697) and lipoproteins (p=0.713)presented a significant association.Conclusion: Considering the clinical values analyzed, a significant association was observed between clinical values of metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD).
No takes yet. Share an insight, caveat, or question.
Valenzuela et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: